| Oct 29 |
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
|
| Oct 28 |
Evoke Pharma Shares Soar on Positive Data for Gimoti Nasal Treatment in Diabetic Gastroparesis
|
| Oct 28 |
Evoke stock rockets 90% on study of Gimoti in GLP-1 users
|
| Oct 28 |
Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®
|
| Oct 23 |
Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting
|
| Oct 22 |
Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors
|
| Oct 1 |
Evoke Pharma announces proceeds from existing warrants and board expansion
|
| Oct 1 |
Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion
|
| Sep 19 |
Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments
|
| Sep 9 |
Evoke Pharma to Participate in Gastroenterology and Hepatology Advanced Practice Providers (GHAPP) Annual Conference
|
